Ever
1 products tracked · names used in filings: Ever
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 01 Oct 2026🇺🇸 FDA approval
FDA approves Trabectedin (trabectedin): new formulation or manufacturer
Ever; NDA219617; New formulation or manufacturer; powder · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Trabectedin trabectedin | Approved | 2026-10-01 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.